Ireland
--:--IST
Active, not recruiting Not applicable

Evaluating the Effectiveness of an Online Cognitive Behavioral Therapy Program for University Students With Depression and/or Anxiety

NCT07246239 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2025-09-15
Last updated
2026-05-05

Condition(s) studied

Anxiety and Depression

Investigational drug(s) / intervention(s)

VIVIM (Viure la Vida al Màxim/Vivir la Vida al Máximo)Counseling

VIVIM (Viure la Vida al Màxim/Vivir la Vida al Máximo): This is the Internet-based CBT program

Counseling: This is the type of support that is offered from the university counseling services

Study summary

The goal of this clinical trial is to learn if an Internet-based self-help program called VIVIM can help university students with depression and/or anxiety. The main question investigadors want to answer is:

\* Does the VIVIM program help participants to feel less depressed and/or anxious? The investigators will compare the VIVIM program with the usual psychological support that university counselling services offer to students.

Participants will:

* Be randomly assigned to either use the VIVIM program or receive usual help from university's counselling service.
* Fill out online questionnaires three times: at the beginning, 10 weeks and 6 months after being assigned either the VIVIM program or usual care.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * To be enrolled as an undergraduate or postgraduate at of the participating Spanish universities. * To report at least moderate symptoms of depression (PHQ\>o= 10) and/or anxiety (GAD-7\>o= 10). Exclusion Criteria: * To self-report having been diagnosed with bipolar and/or psychotic disorder. * To report to be currently receiving psychotherapy/counselling and/or pharmacological treatment for emotional problems. * To be unable to read, speak or understand Spanish. * To be at risk of suicide.

Primary outcome measure(s)

  • Anxiety — From enrollment to 6 months after being randomized
    The Generalized Anxiety Disorder \[GAD-7\] will be used. The total score ranges from 0-21, with a higher score indicating higher symptoms severity
  • Depression — From enrollment to 6 months after being randomized
    The Patient Health Questionnaire-9 item \[PHQ-9\] will be used. The total score ranges from 0 to 27, with a higher score indicating a higher symptom severity

Trial sites (3)

FacilityCityRegionStatus
Blanquerna - Universitat Ramon Llull Barcelona Barcelona
Universitat de Girona Girona Girona
Universitat Rovira i Virgili Tarragona Tarragona
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07246239 on ClinicalTrials.gov ↗ ← All trials in Spain